The development and use of Actiphage® to detect viable mycobacteria from bovine tuberculosis and Johne’s disease-infected animals

Benjamin M.C. Swift*, Nathan Meade, Elsa Sandoval Barron, Malcolm Bennett, Tania Perehenic, Valerie Hughes, Karen Stevenson, Catherine E.D. Rees

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

Here, we describe the development of a method that exploits bacteriophage D29 as a lysis agent for efficient DNA extraction from low numbers of mycobacterial cells. This method (Actiphage®) used in combination with PCR achieved rapid and sensitive (LOD ≤ 10 cell ml−1) detection and identification of viable, pathogenic mycobacteria in blood samples within 6 h. We demonstrate that mycobacteriophage D29 can be used to detect a range of mycobacteria from clinical blood samples including both Mycobacterium tuberculosis complex and Mycobacterium avium subsp. paratuberculosis without the need for culture and confirms our earlier observations that a low-level bacteraemia is associated with these infections in cattle. In a study of M. bovis-infected cattle (n = 41), the sensitivity of the Actiphage® method was 95 % (95 % CI; 0.84–0.99) and specificity was 100 % (95% CI; 0.92–1). We further used Actiphage® to demonstrate viable Mycobacterium avium subsp. paratuberculosis is present in the blood of Johne’s infected cattle. This method provides a revolutionary new tool for the study of infections caused by these difficult to grow pathogens.

Original languageEnglish (US)
Pages (from-to)738-746
Number of pages9
JournalMicrobial Biotechnology
Volume13
Issue number3
DOIs
StatePublished - May 1 2020

Funding

Research England, (Grant/Award Number: 'CCF-17-7779') The authors would like to thank veterinarians and farmers with their help in obtaining samples for this research. BS was sponsored by a University of Nottingham Hermes grant and is currently and BloomsburySET Research Fellow, Research England. ES was sponsored by Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico. NM & WH were sponsored by a BBSRC DTP studentships, and TP was sponsored by PBD Biotech Ltd. The authors would like to thank veterinarians and farmers with their help in obtaining samples for this research. BS was sponsored by a University of Nottingham Hermes grant and is currently and BloomsburySET Research Fellow, Research England. ES was sponsored by Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico. NM & WH were sponsored by a BBSRC DTP studentships, and TP was sponsored by PBD Biotech Ltd.

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biochemistry
  • Applied Microbiology and Biotechnology

Fingerprint

Dive into the research topics of 'The development and use of Actiphage® to detect viable mycobacteria from bovine tuberculosis and Johne’s disease-infected animals'. Together they form a unique fingerprint.

Cite this